| Literature DB >> 33877878 |
Joshua R Astley1,2, Jim M Wild2, Bilal A Tahir1,2.
Abstract
The recent resurgence of deep learning (DL) has dramatically influenced the medical imaging field. Medical image analysis applications have been at the forefront of DL research efforts applied to multiple diseases and organs, including those of the lungs. The aims of this review are twofold: (i) to briefly overview DL theory as it relates to lung image analysis; (ii) to systematically review the DL research literature relating to the lung image analysis applications of segmentation, reconstruction, registration and synthesis. The review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 479 studies were initially identified from the literature search with 82 studies meeting the eligibility criteria. Segmentation was the most common lung image analysis DL application (65.9% of papers reviewed). DL has shown impressive results when applied to segmentation of the whole lung and other pulmonary structures. DL has also shown great potential for applications in image registration, reconstruction and synthesis. However, the majority of published studies have been limited to structural lung imaging with only 12.9% of reviewed studies employing functional lung imaging modalities, thus highlighting significant opportunities for further research in this field. Although the field of DL in lung image analysis is rapidly expanding, concerns over inconsistent validation and evaluation strategies, intersite generalisability, transparency of methodological detail and interpretability need to be addressed before widespread adoption in clinical lung imaging workflow.Entities:
Mesh:
Year: 2021 PMID: 33877878 PMCID: PMC9153705 DOI: 10.1259/bjr.20201107
Source DB: PubMed Journal: Br J Radiol ISSN: 0007-1285 Impact factor: 3.629
Figure 1.Simplified diagrams of the processes of forward propagation (left) and backpropagation (right) for a neural network with two hidden layers. The neural network is represented as a series of nodes, each of which contains a weight and bias. The weight and bias are combined using the activation function to produce an activation that impacts the strength of connections within the network. Once an input has been passed through the network, it is compared to a desired output, such as an expert segmentation of an anatomical region of interest, to produce a loss. This loss is used to propagate changes to weights and biases, hence, changing the strength of connections for the subsequent example. The continued repetition of this two-step process is known as network training.
Figure 2.Glossary of key technical terms related to deep learning and image analysis. ANN, artificial neural network.
Figure 3.Illustration of three common types of deep learning architectures used in medical imaging: (a) CNN), (b) RNN and (c) GAN. In the lung image analysis examples given, the CNN and RNN are used for image segmentation while the GAN is used for image synthesis. CNN, convolutional neural network; GAN, generative adversarial network; RNN, recurrent neural network.
Summary of common pre-processing techniques used for lung image analysis tasks, including values prevalent in the literature
|
|
|
|
|
|
|---|---|---|---|---|
|
| The process of constraining the pixel values of an image to be between predefined values. | CT, MRI | CT intensity: | Wang et al. (2018),[ |
|
| The process of transforming the distribution of image pixels to some distribution which is standardised across images. | CT, MRI, X-ray | Normalisation: [0,1] | Wang et al. (2018),[ |
|
| The process of removing noise from images in order to improve their quality. | CT, MRI | Gaussian, adaptive patch-based | J.Xu & Liu (2017),[ |
|
| A technique to correct for the low-frequency bias field that corrupts MR images. | HP gas MRI, MRI | N3/N4 bias correction | Tustison et al. (2019),[ |
|
| Cropping refers to the process of removing unwanted outer pixels or voxels of an image prior to being inputted to the network. This includes cropping by manually-defined regions of interest or external body masks. Cropping is commonly used to reduce computational cost and/or eliminate the influence of background voxels. | CT, MRI, X-ray, PET | Cropping to body mask, specific organ or manually-defined region. | Negahdar et al. (2018),[ |
HU, Hounsfield unit; PET, Positron emission tomography.
Modalities included are those for which the pre-processing techniques have been used in the reviewed studies. This is not an exhaustive list of pre-processing techniques used.
Figure 4.Overview of four key categories of evaluation metrics (overlap, distance, error and similarity) used to evaluate the performance of deep learning methods in medical image analysis. Each category contains brief descriptions and mathematical formulations for some common metrics. In these equations, ‘x’ and ‘y’ denote the prediction and target of any deep learning task, respectively.
Figure 5.The search strategy used on Scopus, Web of Science and PubMed to identify relevant studies for inclusion in the review. Further studies that met the selection criteria were identified by handsearching references and through the authors’ input.
Figure 6.PRISMA flowchart of studies identified, screened, assessed for eligibility and included in the literature review analysis. PRISMA, preferred reporting items for systematic reviews and meta-analyses.
Figure 7.Graphical overview of the number of studies per year for the four image analysis applications considered in this review. 2020 values calculated up to 1 April 2020.
Figure 8.Graphical overview of breakdown of deep learning lung image analysis studies reviewed by (a) disease present in patient cohorts, (b) imaging modality and (c) architecture. Absolute numbers of papers are provided in (a, b).
Summary of reviewed studies on deep learning for lung image segmentation. The entries are arranged alphabetically by pulmonary region of interest (ROI), followed by modality
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|
| CT | Whole lung | COPD, IPF | 575 | 2D | ResNet-101 | Clipped −1000 to +1000 HU, Normalisation [0,1] | 5-fold CV | DSC = 0.988 ± 0.012 | |
| CT | Whole lung | Lung cancer | 35 | 3D | U-Net-GAN | LOOCV | DSC = 0.97±0.01 | ||
| CT | Whole lung | NR | 100 | 2D | SegNet | Class grouping, Normalisation [−1000,800] | 40/60 | DSC = 0.98 | |
| CT | Whole lung | Lung cancer | 470 | NR | CNN | 95/5 | DSC = 0.99±0.01 | ||
| CT | Whole lung | Multiple | 83 | 3D | V-Net | Bounding box for lung, cropped to bounding box | 58/42 | DSC( | |
| CT | Whole lung | Lung cancer | 422 | 3D | CNN with spatial constraints | ROI extraction for organ localisation | 71/29 | ROC(Left)=0.954 | |
| CT | Whole lung | NR | 95 | 3D | Deep-CNN | Post-processed hole filling | LOOCV | DSC = 0.984±0.068 | |
| CT | Whole lung | Lung lesion | 908 | 3D | Modified V-Net | Clipped [−1000, 400 HU] | 98/2 | ASD = 0.576 mm | |
| CT | Whole lung | NR | 106 | 2D/3D | FCN VGG16 | Transfer learning from ImageNet ILSVRC‐2014 | 95/5 | JSC = 0.903±0.037 | |
| CT | Whole lung | Lung Cancer | 66 | 3D | U-Net | Cropping to ROI | 55/45 | DSC = 0.95±0.01 | |
| CT | Whole lung | COPD, IPF | 1749 | 3D | Course-Fine ConvNet | Transfer learning from COPDGene and SPIROMICS, fine-tuned on animal model | 92/8 | JSC = 0.99 | |
| CT | Whole lung | Lung cancer | 13 | 2D | Dilated U-Net | Only axial slices selected, clipped −1000 to 3000 HU, Normalisation [0,1] | 94/6 | DSC = 0.99 ± 0.01 | |
| CT | Whole lung | NR | 20 | 2D | MFCNN | gaussian denoising | 50/50 | DSC = 0.754 | |
| CT | Whole lung | NR | 75 | 2D | Mask R-CNN +k-means | NR | DSC = 0.973 ±0.032 | ||
| CT | Whole lung | Multiple | 266 | 2D | U-Net | Body mask, Clipped [−1024, 600 HU], Normalisation [0,1] | 87/13 | DSC = 0.98 ±0.03 | |
| CT | Whole lung | Lung cancer, COPD | 224 | 2D | one layer CNN | Post-processed hole filling | 8-fold CV | DSC = 0.967 ±0.001 | |
| HP gas MRI | Functional lung | NR | 113 | 2D | U-Net | Template-based data augmentation, N4 bias correction, denoising | 65/35 | DSC (HP gas)=0.92 | |
| LDCT | Whole lung | NR | 220 | 2D | CDWN | Normalised [mean = 0] | 91/9 | DSC = 0.95 ± 0.03 | |
| UTE proton MRI | Whole lung | Healthy, CF, asthma | 45 | 2D | CED (U-Net and autoencoder) | Denoising, bias field correction, body mask | 5-fold CV | DSC (right) = 0.97±0.015 | |
| X-ray | Whole lung | Healthy, lung nodules | 247 | 2D | U-Net | 2-fold CV | DSC = 0.980±0.008 | ||
| X-ray | Whole lung | Healthy, Tuberculosis | 138 | 2D | ResNet-18 with FC layer | Scaled to same input size, post processing erosion, dilation, filtering | 73/27 | DSC = 0.936 | |
| X-ray | Whole lung | Healthy, Tuberculosis, lung nodules | 385 | 2D | SCAN (structure correcting adversieral network) | Scaled to same input size | 85/15 | IoU = 94.7±0.4% | |
| X-ray | Whole lung | Healthy, lung nodules | 247 | 2D | Multi task U-Net | Scaled to same input size, post processing hole filling | NR | JSC = 0.959 ± 0.017 | |
| X-ray | Whole lung | Healthy, lung nodules | 247 | 2D | InvertedNet + All-dropout | Normalised [mean = 0, SD = 0] | 3-fold CV | DSC = 0.974 | |
| X-ray | Whole lung | Healthy, Tuberculosis, lung nodules | 385 | 2D | FCN-8+dropout | Scaled to same input size, random cropping | 75/25 | DSC = 0.959 | |
| X-ray | Whole lung | Healthy, Tuberculosis, lung nodules | 385 | 2D | LF-SegNet | Scaled to same input size, random cropping | 48/52 | DSC = 0.951 | |
| X-ray | Whole lung | Healthy, Tuberculosis, lung nodules | 1047 | 2D | Adversarial attention U-Net | Scaled to same input size, CLAHE, Normalisation [−1,1] | 24/76 | DSC = 0.962±0.04 | |
| CT | Lung tumour | Lung cancer | 134 | 3D | HSN (2 | 78/22 | DSC = 0.888±0.033 | ||
| CT, MRI | Lung tumour | Lung cancer | 400 | 2D | Tumour aware semi-supervised Cycle-GAN | Scaled to same input size, Image synthesis from CT to MRI, body mask | 98/2 | DSC = 0.63 ± 0.24 | |
| CT, MRI | Lung tumour | Lung cancer | 405 | 2D | Tumour aware pseudo MR and T2w MR U-Net | Scaled to same input size, Image synthesis from CT to MR, Clipped [−1000,500 HU] and [0,667], Normalised [−1, 1] | 95/5 | DSC = 0.75±0.12 | |
| MRI | Lung tumour | Lung cancer | 6 | 2D | Adapted FCN | Rescaled 10–95% of intensities, Normalisation [0,1] | 5-fold CV | DSC = 0.91 ± 0.03 | |
| FDG PET, CT | Lung tumour | Lung cancer | 60 | 3D | DFCN Co-Seg U-Net | Scaled to same input size, Clipped [−500,200 HU] and [0.01,20] | 80/20 | DSC (CT) = 0.861±0.037 | |
| PET, CT | Lung tumour | Lung cancer | 84 | 3D | V-Net +feature fusion | Cropped to ROI | 57/43 | DSC = 0.85±0.08 | |
| CT | Lung tumour | NR | 1350 | 3D | P-SiBA | Transfer learning from ImageNet ILSVRC‐2014, Cropped to ROI, Rescaled by +1000 HU and dividing by 3000 and Normalisation [0,1] | NR | DSC = 0.809 ± 0.12 | |
| Micro CT | Lung tumour | Lung cancer | 3 | 3D | JULE CNN + k-means | Body mask, patch extraction | NMI = 0.390 | ||
| CT | Lobes | COPD, ILD | 563 | 3D | Progressive dense V-Net | 48/52 | DSC ( | ||
| CT | Lobes | COPD | 196 | 3D | U-Net | Clipped [-1024,–400 HU] | 80/20 | DSC = 0.956 ± 0.022 | |
| CT | Lobes | COPD, IPF | 1280 | 3D | DenseNet | Clipped −1000 to +1000 HU, Normalisation [0,1] | 5-fold CV | DSC = 0.959±0.087 | |
| CT | Lung lesion | NR | 87 | 3D | DALS CNN | Scaled to same input size, Normalisation [NR] | 90/10 | DSC = 0.869 ± 0.113 | |
| CT | Lung lesion | Tuberculosis | 338 | 2D | GoogLeNet CNN | Images cropped into four quadrants | 80/20 | IoU = 0.95 | |
| CT | Lung fissure | COPD, Lung cancer | 5327 | 3D | Two Seg3DNets | Clipped [-1024,–200 HU], Linear rescaling | 30/70 | ASD = 1.25 | |
| MRI | Lung defect region | NR | 35 | 2D | GAE-LAE RNN with LCI Loss | Z-normalisation [−4,4], Lung mask, Normalisation [0,1], Histogram stretching | 80/20 | Qualitative evaluation - 42% images rated ‘very good’, 19% rated ‘perfect’ | |
| CT | ILD pattern | ILD | 46 | 2D | AtlasNet | 37/63 | DSC = 0.677 | ||
| CT | ILD pattern | ILD | 172 | 2D | FCN-CNN | Pre-computed lung mask | 5-fold CV | Accuracy = 81.8% | |
| CT | ILD pattern | COP, UIP, NSIP | 647 | 2D | U-Net | 88/12 | DSC = 0. 988 ± 0.006 | ||
| CT | ILD pattern | ILD | 17 | 2D | CNN based CRF unary classifier | Transfer learning from ImageNet, Pre-computed lung mask | Accuracy = 92.8% | ||
| CT | Diffuse lung disease | NR | 372 | 3D | U-Net | 5-fold CV | DSC = 0.780±0.169 | ||
| MRI | Foetal lung | NR | 18 | 2D | BIFSeg P-Net | Trained on different organs, Image specific fine-tuning | 66/33 | DSC = 0.854±0.059 | |
| MRI | Foetal lung | Healthy, IUGR | 55 | 3D | DeepCut CNN + CRF | Bounding box for ROI, Bias correction, Normalisation [mean = 0], Transfer learning from LeNet | 5-fold CV | DSC = 0.749±0.067 | |
| Cone-beam CT | Diaphragm | Lung cancer | 10 | 2D | Mask R-CNN | Scaled to same input size | 9-fold CV | Mean error = 4.4 mm | |
| CT | Airways | NR | 38 | 3D | Spatial-CNN (U-Net) | Random cropping | 92/8 3-fold MCCV | DSC = 0. 887 ± 0.012 | |
| CT | Airways | Lung cancer | 32 | 3D | U-Net GNN | Bounding box for ROI | 63/37 | DSC = 0.885 | |
| CT | Airways | COPD | 89 | 2D | 2.5D CNN | Clipped [−700,700 HU] | 78/22 | Mean Branch detected = 65.7% | |
| CT | Airways | Healthy, CF, CVID | 24 | 3D | U-Net | Bounding box for ROI | 75/25 | DSC = 0.8 |
ACD, Average contour distance; AD, Average distance; ASD, Average surface distance; CDWN, Convolutional deep wide network; CE, Classification error; CF, Cystic fibrosis; CLAHE, Contrast limited adaptive histogram equalisation; CNN, Convolutional neural network; CO, Centreline overlap; COPD, Chronic obstructive pulmonary disorder; CV, Cross-validation; CVID, Common variable immunodeficiency disorders; DSC, Dice similarity coefficient; FDG, Fluorine-18‐fluorodeoxyglucose; GAN, Generative adversarial network; HD95, Hausdorff distance 95%; HD, Hausdorff distance; HSD, Hausdorff surface distance; HU, Hounsfield unit; ILD, Interstitial lung disease; IPF, Idiopathic pulmonary fibrosis; IUGR, Intrauterine growth restriction; IoU, Intersection over union; JSC, Jaccard similarity coefficient; LOOCV, Leave-one-out cross-validation; MAP, Mean average precision; MCCV, Monte carlo cross-validation; MSD, Mean surface distance; NMI, Normalised mutual information; NR, Not reported; NSIP, Nonspecific interstitial pneumonia; PVD, Percent ventilated defect; RMSE, Root mean square error; ROC, Receiver operating characteristic; ROI, Region of interest; SD, Standard deviation; SDSD, Standard deviation of surface distances; UIP, Usual interstitial pneumonia; VE, Volume error; VR, Relative volume ratio; VS, Volumetric similarity.
The entries are arranged alphabetically by pulmonary ROI, followed by modality.
The training data set includes internal validation data.
Figure 9.Example images from the authors’ own work using deep learning for hyperpolarised gas MRI segmentation. The 129Xe MR ventilation images are taken from three subjects in a testing set, a healthy volunteer, asthma patient and cystic fibrosis patient. The patient images selected are characterised by significant ventilation defects. These are compared to expert segmentations of the same image. DSC values are displayed for all images. DSC, Dice similarity coefficient.
Summary of reviewed studies using deep learning for lung image registration
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|
| 4DCT | Lung cancer | DIR-LAB, CREATIS | 17 | 3D | Modified VGG | Synthetic DVFs for data augmentation | 42 (CREATIS) / 58 (DIR-LAB) | TRE = 4.02±3.08 | |
| 4DCT | Lung cancer | DIR-LAB, CREATIS | 17 | 3D | Modified U-Net | Synthetic DVFs for data augmentation, Resized, Pre-computed body mask, intensity-based lung mask < −250 HU | 42 (CREATIS) / 58 (DIR-LAB) | TRE = 2.17±1.89 mm | |
| 4DCT | Lung cancer | DIR-LAB, CREATIS | 17 | 2D | Conv2Wrap (Linear and Deformable ConvNet) | 58 (DIR-LAB) / 42 (CREATIS) | DSC = 0.90 | ||
| 4DCT | Lung cancer | DIR-LAB, CREATIS | 86 | 3D | GDL-FIRE4D U-Net with VarReg | Normalisation [0,1], Cropped to same input size, Pre-computed body mask | 69/31 (DIR-LAB, CREATIS, In house) | TRE (DIR-LAB) = 2.50±1.16 mm | |
| 4DCT | Lung cancer | DIR-LAB, CREATIS, Sunnybrook | 31 | 3D | U-Net one-shot learning | Pre-computed body mask, Normalisation [mean = 0, SD = 1] | LOOCV (DIR-LAB) | TRE (DIR-LAB) = 1.83±2.35 mm | |
| 4DCT | Lung cancer | DIR-LAB | 20 | 3D | LungRegNet (CourseNet, FineNet) | Vessel enhancement, Clipped at −700 HU | 5-fold CV, DIR-LAB testing | MAE (in house)=52.1±18.4 | |
| 4DCT | Lung cancer | DIR-LAB, SPARE | 32 | 3D | MJ-CNN | Clipped [-1000,–200 HU], Normalisation [0,0.2] | 75 (SPARE, DIR-LAB) / 25 (DIR-LAB) | TRE = 1.58±1.19 mm | |
| 4DCT, CT | Lung cancer | DIR-LAB, NLST | 2070 | 3D | DLIR framework ConvNet | Clipped [-1000,–200 HU], Normalisation [0,1] | 99 (NLST) / 1 (NLST, DIR-LAB) | DSC (NLST) = 0.75±0.08 | |
| CT | COPD | 19 | 3D | RegNet CNN | Synthetic DVFs for data augmentation, Initial affine registration | 63/37 | TRE = 4.39 ± 7.54 mm | ||
| CT, 4DCT | Lung cancer, COPD | SPREAD, DIR-LAB | 39 | 3D | RegNet CNN (U-Net) | Synthetic DVFs for data augmentation, Initial affine registration | 54 (SPREAD, DIR-LAB COPD) / 46 (SPREAD, DIR-LAB) | TRE (DIR-LAB) = 1.86±2.12 mm | |
| CT | COPD | DIR-LAB | 10 | 3D | CNN | Cropped to lung region | LOOCV | TRE = 3.00 ± 0.48 mm | |
| CT, MRI | COPD | COPDGene | 1000 | 2D | UMDIR-LaGAN | Cross-modality registration, transformation into domain invariant latent space | 90/10 | DSC = 0.967±0.03 | |
| CT, CBCT | Healthy, COPD, Lung cancer | DIR-LAB, VCU | 27 | 3D | CNN | Normalisation [0,1] | 37 (DIR-LAB) / 63(VCU) | AUC-ROC = 0.882±0.11 CI=68% | |
| X-ray | Healthy, Lung nodule | JSRT | 247 | 2D | U-Net | Normalisation [0–1], Domain adaption Cardiac MR | 81/19 | MAD ≈ 6.3 | |
| X-ray | Multiple | NIH-ChestXray14 | 420 | 2D | JRSNet (cycleGAN with U-Net) | Joint segmentation and registration | NR | TRE = 7.75 mm | |
| MRI | Systemic sclerosis, healthy | 41 | 3D | CNN with transformation layer | Clipped [0, 1300], Normalisation [0,1] | 68/32 | DSC = 0. 915 ± 2.33 |
AUR-ROC, Area under curve-receiver operator characteristic; CMD, Contour mean distance; CNN, Convolutional neural network; COPD, Chronic obstructive pulmonary disorder; CV, Cross-validation; DLIR, Deep learning image registration; DSC, Dice similarity coefficient; HD, Hausdorff distance; HU, Hounsfield unit; JSC, Jaccard similarity coefficient; LOOCV, Leave-one-out cross-validation; MAD, Mean absolute differences; MAE, Mean absolute error; MCD, Mean contour distance; MRF, Markovian random field; TRE, Target registration error; VGG, Visual geometry group.
Summary of reviewed studies using deep learning for lung image reconstruction
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| 4D cone beam CT | Lung cancer | 16 | 2D | Sino-Net (Modified U-Net) | Cropped to same input size, Sinogram Normalisation [0,1] | 88/12 | RMSE Translational = 1.67 mm | |
| CT | COPD | 60 | 2D | FCN | No sinogram used | Dataset 1: 80/20 | Mean reduction RMSE (Dataset 1) = 65.7±15.8% | |
| CT | Liver lesion | 5413 | 2D | ADAPTIVE-NET CNN | Convert from HU to linear attenuation coefficient | 90/10 | PSNR = 43.15±1.9 | |
| HP Gas MRI | COPD, nodule, PTB, healthy, asthma | 72 | 2D | C-Net and F-Net (U-Net based) | Under sampled K-space (AF = 4), Removed SNR below 6.6, Normalisation [0,1] | NR | MAE = 4.35% | |
| [ | Liver Cancer | 128 | 2D | CNN | Initial filtered back projection | 94/6 | LSF = 5.1% |
CNN, Convolutional neural network; CNR, Contrast to noise ratio; COPD, Chronic obstructive pulmonary disorder; EIT, Electrical impedance tomography; HU, Hounsfield unit; LSF, Lung shunting fraction; MAE, Mean absolute error; PSNR, Peak signal to noise ratio; PTB, Pulmonary tuberculosis; RMSE, Root mean square error; SSIM, Structural similarity index metric; VDP, Ventilation defect percentage; VDP, Volume defect percentage; 99mTc-MAA, Technetium-99m macroaggregated albumin.
The training data set includes internal validation data
Summary of reviewed studies using deep learning for lung image synthesis
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|
| CT ⇒ FDG PET | Lung cancer | 50 | 2D | Multichannel-GAN (U-Net) | Manual segmentation of tumour/lymph nodes, axial slices containing tumours only | 50/50 | MAE = 4.6 | |
| CT ⇒[ | Lung cancer | 54 | 2D | Conditional GAN | Resized images, segmentation and removal of bone, soft tissue and heart | 91/9 | MS-SSIM = 0.87 | |
| 4DCT ⇒ CT ventilation | Lung cancer, COPD | 82 | 2D | Deep CNN | Images cropped to ROI | 10-fold CV | MSE = 7.6% | |
| 4DCT ⇒[ | Lung cancer, oesophageal cancer | 50 | 2D | U-Net | Pre-computed lung mask, normalisation [0,1], post-processing normalisation [90th percentile] | 10-fold CV | Spearman’s | |
| CT ⇒[ | Lung cancer | 30 | 3D | U-Net | Clipped [-1000,–300 HU] for segmentation, normalisation [0,1] | 83/17 | Correlation coefficient = 0.53 ± 0.14 | |
| Ultrasound ⇒ MRI | NR | 7 | 3D | LRCN | PCA = 10 components | 66/33 (conducted in time segments) | SSE = 39.0 ± 12 | |
| MRI ⇒ CT | NR | 41 | NR | GAN (U-Net) | Normalisation [NR], pre-computed body mask | 90/10 | 3D γ index passing rate 99.2% |
CNN, Convolutional neural network; COPD, Chronic obstructive pulmonary disease; FDG, Fluorine-18‐fluorodeoxyglucose; GAN, Generative adversarial network; HU, Hounsfield unit; LRCN, Long-term recurrent convolutional network; MAE, Mean absolute error; MSE, Mean square error; MS-SSIM, Multi-scale structural similarity index metric; NR, Not reported; PCA, Principle component analysis; PSNR, Peak signal to noise ratio; ROI, Region of interest; SSE, Sum of squared error; 99mTc-MAA, Technetium-99m macroaggregated albumin.